Clinical trials are carefully designed investigations to determine the natural course of a cardiac condition, and often to test the value (safety and benefit) of a treatment modality. Clinical trials are necessary preludes to the widespread introduction of new treatment. Clinical trials are often designed so that a standard treatment is compared to a newer treatment, and some are designed to test a new treatment in comparison to placebo.

Clinical trials are frequently sponsored by the National Institute of Health, but other scientific organizations or industrial entities may sponsor and support these trials. Clinical trials may make available newer or innovative treatments not approved for general usage.

As a leading academic medical center and academic affiliate of Columbia University College of Physicians and Surgeons, St. Luke's-Roosevelt Hospital Center is a leader in the design, conduct, and interpretation of clinical trials for the care of the cardiac patient. Below you will find a listing of our currently active clinical trial programs.

REVERT
Principal Investigator: Daniel Swistel, MD
Sponsor: Medtronic, Inc.
Contact: Robin Knox, RN or Ammy Malinay, RN; 212-523-4007
Design: Subjects requiring Biventricular pacemaker also known as Cardiac resynchronization therapy (CRT) will be randomized to either conventional placement of the Left ventricular lead or Robotic placement of the left ventricular lead. This study is comparing the best position for optimizing CRT.
Target Number of Patients: 30
Duration: 1 year

For a referral to an expert cardiologist at Roosevelt Hospital in New York City, call 877.996.9334.